Pierre Lavertu, MD, FRCS(C), FACS

 

\Director, Head and Neck Surgery and Oncology
Otolaryngology - Head and Neck Surgery
Case Western Reserve University School of Medicine

 

 

 

MEDICAL EDUCATION
University of Montreal – M.D.  (1976)

GRADUATE MEDICAL EDUCATION
Residency
Otolaryngology - University of Montreal (1977-1981)

Fellowships
Head and Neck - University of Montreal (1981-1982)
Head and Neck - Cleveland Clinic (1982-1983)

CLINICAL INTERESTS
Head & Neck Oncology, Parotid Surgery, Thyroid and Parathyroid Surgery, Sino-nasal Oncology

SELECTED PUBLICATIONS
1. Yao, M, Lu, M, Savvides PS, Rezaee RP, Zender, CA, Lavertu P, Buatti JM, Machtay M: Distant Metastases in Head-and-Neck Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy. Int J Radiation Oncol Biol Phys, 83(2):684-9,2012.

2. Savvides P, Nagaiah G, Lavertu P, Fu P, Wright JJ, Chapman R, Wasman J, Dowlati A, Remick SC: Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid. Thyroid 23(5):600-4, 2013.

3. Jaber JJ, Zender CA, Mehta V, Davis K, Ferris RL, Lavertu P, Rezaee RP, Feustel PJ, Johnson JT: Multi-institutional Investigation of the Prognostic Value of Lymph Nodal Yield in Advanced Stage Oral Cavity Squamous Cell Carcinoma. Head & Neck, 36(10):1446-52, 2014.

4. Rodriguez CP, Adelstein DJ, Rybicki LA, Savvides P, Saxson JP, Koyfman SA, Greskovich JF, Yao M, Scharpf J, Lavertu P, Wood BG, Burkey BB, Lorenz RR, Rezaee RP, Zender CA, Ives DI. A Randomized Phase III Study of Tw Cisplatin-based Chemoradiation (CCRT) Regimens in Locally Advanced Head and Neck Squamous Cell Carcinoma(LAHNSCC: The impact of changing disease epidemiology n contemporary trial design. Head & Neck. In press.

5. Yao M, Galanopooulos N, Lavertu P, Fu P, Gibson M, Rezaee R, Zender CA, Wasman J, Machtay M, Savvides P. A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Published online in Head & Neck, 2014. DOI 10.23813.